• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL TACTIFLEX¿ ABLATION CATHETER, SENSOR ENABLED¿; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL TACTIFLEX¿ ABLATION CATHETER, SENSOR ENABLED¿; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION Back to Search Results
Model Number A-TFSE-D
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Cardiac Perforation (2513)
Date of Event 06/17/2025
Type of Reportable Event Serious Injury
Event or Problem Description
During the procedure, a cardiac tamponade was noted for which a pericardiocentesis was performed to stabilize the patient.Ablation of the left-lateral (ll) accessory pathway was performed with retro-aortic approach with high contact force.The rep told the physician he was using a log of force.Irrigation was performed with 20-25 g max (just one reached 40 g for just few seconds).The patient became hypotensive, and an echocardiogram revealed a cardiac tamponade for which a pericardiocentesis was performed to stabilize the patient.
 
Additional Manufacturer Narrative
Additional information: g3, h2, h3, h6.The results of the investigation are inconclusive since the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed.Based on the information received, the cause of the reported tamponade remains unknown.Per the ifu, cardiac tamponade and pericardial effusion are known risks during the use of this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TACTIFLEX¿ ABLATION CATHETER, SENSOR ENABLED¿
Common Device Name
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
wendy mccarty
5050 nathan lane north
plymouth, MN 55442
6517565400
MDR Report Key22319877
Report Number3005334138-2025-00379
Device Sequence Number12999005
Product Code OAE
UDI-Device Identifier05415067034656
UDI-Public(01)05415067034656(10)10562049(17)250930
Combination Product (Y/N)N
Initial Reporter CountryIT
PMA/510(K) Number
P220013
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 09/19/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date09/30/2025
Device Model NumberA-TFSE-D
Device Catalogue NumberA-TFSE-D
Device Lot Number10562049
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/17/2025
Supplement Date Received by Manufacturer09/05/2025
Initial Report FDA Received Date06/24/2025
Supplement Report FDA Received Date09/19/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured10/14/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age70 YR
Patient SexFemale
Patient Weight57 KG
-
-